Carl Icahn Takes a Stab At Beaten-Up Genzyme (GENZ), Can He Spark a Rally

Carl Icahn's Icahn Capital hedge fund disclosed a new 1,450,800 share stake in Genzyme Corp. (Nasdaq: GENZ).

This is interesting as GENZ has been getting pounded recently due to quality issues with the FDA. Icahn has had success with biotech/pharma.

Maybe Icahn can spark a rally in the stock.

Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• Musalem: strong growth and investment influencing bond market - CNBC
• Scorpion Capital says short Twist Biosciences